DENVER--(BUSINESS WIRE)--Colorado BioScience Association (CBSA) today announced the largest-ever number of investors and strategic partners will gather at the 2015 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC) to hear presentations from 30 inventive life science companies from five states. The 2015 conference, to be held in Vail, Colo. on September 23 and 24, will connect high-profile angel investors, venture capitalists and representatives from large life science corporations to meet leaders from emerging and established life science companies from Arizona, Colorado, Montana, New Mexico and Utah. A total of 48 investors representing 35 firms and strategic partners will attend.
April Giles, President and CEO of Colorado BioScience Association (CBSA), said:
“The 30% growth in attendance at this year’s Rocky Mountain Life Science Investor and Partnering Conference by those looking for new investment opportunities demonstrates the outstanding infrastructure and talented workforce for advancing bioscience businesses in the Rocky Mountain region. We are pleased to provide new opportunities for our region’s most inventive companies to share their success stories with investors.”
The participating investment firms include:
5AM
Ventures, Menlo Park, Calif.
Agilent
Research Laboratories, Santa Clara, Calif.
Aphelion
Capital, San Francisco
Arboretum
Ventures, Ann Arbor, Mich.
Artiman
Ventures Palo Alto, Calif.
Athyrium
Capital Management, New York
Baird
Capital, Chicago
Boulder
Ventures, Boulder, Colo.
Broadview
Ventures, Boston
Catholic
Health Initiatives Venture Fund, Denver
Colorado
Impact Fund, Denver
Colorado
Institute for Drug, Device and Diagnostic Development, Aurora, Colo.
Crestone
Capital, Boulder, Colo.
CSU
Ventures, Fort Collins, Colo.
GE
Healthcare Financial Services, Chicago
GCM
Grosvenor, Chicago
GlaxoSmithKline,
Philadelphia
Green
Park & Golf Ventures, Dallas
HealthQuest
Capital, Menlo Park, Calif.
H.I.G
Capital, Miami
High
Country Venture, Boulder, Colo.
Hyalescent
Ventures, Phoenix
KMG
Capital, Denver
Longitude
Capital, Menlo Park, Calif.
Medtronic
plc, Minneapolis
Mercury
Fund, Houston
MS
Ventures, Boston
MTS
Health Partners, L.P., New York
New
Enterprise Associates, Timonium, Md.
Osage
University Partners, Bala Cynwyd, Pa.
Partisan
Management Group Boulder
Research
Corporation Technologies, Tucson, Ariz.
Sanderling
Ventures, San Mateo, Calif.
Teijin
Pharma, Tokyo
Volcano
Capital, New York
Wexford
Capital, West Palm Beach, FL
Following a breakfast keynote presentation on the current IPO climate by Jon Norris of Silicon Valley Bank, investors and partners will have the opportunity to hear pitches from the 30 companies chosen to present. Each company will have 20 minutes to tell its story.
The event, to be held in Vail, Colo. on September 23 and 24, attracts leading investors and executives to meet representatives from the 30 companies chosen by the Rocky Mountain Life Science Investor and Partnering Conference selection committee.
The 2015 Rocky Mountain Life Science Investor & Partnering Conference – spearheaded by the Colorado BioScience Association in collaboration with associations in Arizona, Montana, New Mexico and Utah — will open with a cocktail networking reception at the Vail Marriott Mountain Resort in Lionshead on September 23, followed by a full day of company pitch presentations on September 24. A full agenda can be found online.
Connect with CBSA: Twitter @COBioscience, Facebook and LinkedIn
Event hashtag: #RockyMtnBioInvest
About the Colorado BioScience Association
The Colorado BioScience Association (CBSA) is a not-for-profit corporation providing services and support for Colorado's growing biosciences industry. With more than 350 members, CBSA actively works to promote the growth of the industry by working for a better business environment, grow the state's bioscience workforce, advocate for policies that support a strong bioscience industry in the state, and speak with a single voice on behalf of the industry. For more information, visit http://www.cobioscience.com.
